ONC and ONY Related Headlines
Go Back- Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
- Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
- Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results
- Oncolytics plans FDA talks for pancreatic cancer drug trial
- Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
ONC and ONY Related Press Releases
Go Back- Oncolytics Biotech® Announces Update for Potential First-Line Pancreatic Cancer Registration Study
- Oncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for Pelareorep
- Oncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial Results
- Oncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-End
